Vas Narasimhan, Novartis CEO (Patrick Straub/​EPA-EFE/​Shutterstock)

No­var­tis pays $678M for kick­back scheme as Vas Narasimhan tries to dis­tance phar­ma gi­ant from shady be­hav­ior

No­var­tis has reached an­oth­er large set­tle­ment to re­solve mis­con­duct al­le­ga­tions, agree­ing to pay more than $678 mil­lion to set­tle claims that it had spent hun­dreds …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.